Cargando…
Plasma sCD14 as a Biomarker to Predict Pulmonary Exacerbations in Cystic Fibrosis
BACKGROUND: One in four cystic fibrosis (CF) patients diagnosed with a pulmonary exacerbation will not recover their baseline lung function despite standard treatment. This highlights the importance of preventing such events. Clinical decision-making can be improved through a simple blood test that...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930718/ https://www.ncbi.nlm.nih.gov/pubmed/24586701 http://dx.doi.org/10.1371/journal.pone.0089341 |